Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
almorexant (1 trial)
zolpidem (ambien) (1 trial)
lanreotide (somatuline depot) (1 trial)
talarozole (1 trial)
Acne Vulgaris (Phase 2)
Bile Reflux (Phase 2)
Esophagitis (Phase 2)
Esophagitis, Peptic (Phase 2)
Gastroesophageal Reflux (Phase 2)
Sleep Initiation and Maintenance Disorders (Phase 3)
Trials (3 total)
Trial APIs (4 total)